(Q36409238)

14 August 2017

1 reference

title

How to reduce radiation-related toxicity in patients with cancer of the head and neck (English)

1 reference

14 August 2017

1

Adam S Garden

1 reference

14 August 2017

Jan S Lewin

2

1 reference

PubMed ID

16507224

14 August 2017

Mark S Chambers

series ordinal

3

1 reference

PubMed ID

16507224

14 August 2017

language of work or name

1 reference

1 March 2006

1 reference

14 August 2017

Current Oncology Reports

1 reference

14 August 2017

8

1 reference

14 August 2017

2

1 reference

14 August 2017

140-145

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-006-0049-x

14 August 2017

0 references

cites work

Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer

1 reference

12 December 2020

Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis

1 reference

12 December 2020

A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.

1 reference

12 December 2020

Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review

1 reference

12 December 2020

Pharyngeal transport dysfunction consequent to an organ-sparing protocol.

1 reference

12 December 2020

Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer

1 reference

12 December 2020

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

12 December 2020

Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer

1 reference

12 December 2020

Impact of tongue base and posterior pharyngeal wall biomechanics on pharyngeal clearance in irradiated postsurgical oral and oropharyngeal cancer patients.

1 reference

12 December 2020

Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study

1 reference

12 December 2020

Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management

1 reference

12 December 2020

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer

1 reference

12 December 2020

Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy

1 reference

12 December 2020

Antimicrobial therapy to prevent or treat oral mucositis

1 reference

12 December 2020

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

1 reference

12 December 2020

Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report

1 reference

12 December 2020

The pathobiology of mucositis

1 reference

12 December 2020

Radiochemotherapy with amifostine cytoprotection for head and neck cancer

1 reference

12 December 2020

Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.

1 reference

12 December 2020

Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial

1 reference

12 December 2020

Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?

1 reference

12 December 2020

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

1 reference

12 December 2020

Target coverage for head and neck cancers treated with IMRT: review of clinical experiences

1 reference

12 December 2020

Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer

1 reference

12 December 2020

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

1 reference

12 December 2020

Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer

1 reference

12 December 2020

The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory.

1 reference

12 December 2020

Palifermin for oral mucositis after intensive therapy for hematologic cancers

1 reference

12 December 2020

10.1007/S11912-006-0049-X

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16507224